These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 34007021)
1. Oncological and functional outcome after partial prostate HIFU ablation with Focal-One Dellabella M; Branchi A; Di Rosa M; Pucci M; Gasparri L; Claudini R; Carnevali F; Cecchini S; Castellani D Prostate Cancer Prostatic Dis; 2021 Dec; 24(4):1189-1197. PubMed ID: 34007021 [TBL] [Abstract][Full Text] [Related]
2. Focal High-intensity Focused Ultrasound Targeted Hemiablation for Unilateral Prostate Cancer: A Prospective Evaluation of Oncologic and Functional Outcomes. Feijoo ER; Sivaraman A; Barret E; Sanchez-Salas R; Galiano M; Rozet F; Prapotnich D; Cathala N; Mombet A; Cathelineau X Eur Urol; 2016 Feb; 69(2):214-20. PubMed ID: 26164416 [TBL] [Abstract][Full Text] [Related]
3. HIFU as salvage first-line treatment for palpable, TRUS-evidenced, biopsy-proven locally recurrent prostate cancer after radical prostatectomy: a pilot study. Asimakopoulos AD; Miano R; Virgili G; Vespasiani G; Finazzi Agrò E Urol Oncol; 2012 Sep; 30(5):577-83. PubMed ID: 21292508 [TBL] [Abstract][Full Text] [Related]
4. High-intensity Focused Ultrasound (HIFU) as salvage therapy for radio-recurrent prostate cancer: predictors of disease response. Dason S; Wong NC; Allard CB; Hoogenes J; Orovan W; Shayegan B Int Braz J Urol; 2018; 44(2):248-257. PubMed ID: 29211405 [TBL] [Abstract][Full Text] [Related]
5. Salvage partial gland ablation for recurrent prostate cancer following primary partial gland ablation: Functional and oncological outcomes. Qaoud Y; Herrera-Caceres JO; Bass R; Berjaoui MB; Tiwari R; Kenk M; Lajkosz K; Finelli A; Perlis N; Klotz L; Fleshner N Urol Oncol; 2022 Jul; 40(7):343.e1-343.e6. PubMed ID: 35537905 [TBL] [Abstract][Full Text] [Related]
6. Prostate cancer treatment by the latest focal HIFU device with MRI/TRUS-fusion control biopsies: A prospective evaluation. von Hardenberg J; Westhoff N; Baumunk D; Hausmann D; Martini T; Marx A; Porubsky S; Schostak M; Michel MS; Ritter M Urol Oncol; 2018 Sep; 36(9):401.e1-401.e9. PubMed ID: 30093211 [TBL] [Abstract][Full Text] [Related]
7. Salvage Hemiablation High Intensity Focused Ultrasound for unilateral radio-recurrent prostate cancer. Aoun F; Albisinni S; Biaou I; Peltier A; Limani K; Roumeguère T; van Velthoven R Prog Urol; 2019 Oct; 29(12):627-633. PubMed ID: 31400963 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of post-ablation mpMRI as a predictor of residual prostate cancer after focal high intensity focused ultrasound (HIFU) ablation. Khandwala YS; Morisetty S; Ghanouni P; Fan RE; Soerensen SJC; Rusu M; Sonn GA Urol Oncol; 2022 Nov; 40(11):489.e9-489.e17. PubMed ID: 36058811 [TBL] [Abstract][Full Text] [Related]
9. [HIFU therapy of localized prostate cancer using image-guided robotic HIFU Focal One]. Govorov AV; Vasilyev AO; Alaverdyan AI; Kolontarev KB; Pushkar DY Urologiia; 2023 May; (2):83-89. PubMed ID: 37401710 [TBL] [Abstract][Full Text] [Related]
10. Quality of life and functional outcome after infravesical desobstruction and HIFU treatment for localized prostate cancer. Hatiboglu G; Popeneciu IV; Deppert M; Nyarangi-Dix J; Hadaschik B; Hohenfellner M; Teber D; Pahernik S BMC Urol; 2017 Jan; 17(1):5. PubMed ID: 28077116 [TBL] [Abstract][Full Text] [Related]
11. Salvage high-intensity focused ultrasound (S-HIFU) for recurrence after primary radiotherapy of prostate cancer. Long Depaquit T; Campagna J; Bastide C; Baboudjian M; Corral R; Uleri A; Toledano H Fr J Urol; 2024 Jun; 34(5):102633. PubMed ID: 38547931 [TBL] [Abstract][Full Text] [Related]
12. Focal High-intensity Focussed Ultrasound Partial Gland Ablation for the Treatment of Localised Prostate Cancer: A Report of Medium-term Outcomes From a Single-center in the United Kingdom. Johnston MJ; Emara A; Noureldin M; Bott S; Hindley RG Urology; 2019 Nov; 133():175-181. PubMed ID: 31449831 [TBL] [Abstract][Full Text] [Related]
15. Medium-term Oncological Efficacy and Patient-reported Outcomes After Focal High-intensity Focused Ultrasound: The FOXPRO Trial. Westhoff N; Ernst R; Kowalewski KF; Derigs F; Neuberger M; Nörenberg D; Popovic ZV; Ritter M; Stephan Michel M; von Hardenberg J Eur Urol Focus; 2023 Mar; 9(2):283-290. PubMed ID: 36344395 [TBL] [Abstract][Full Text] [Related]
16. Comparing High-Intensity Focal Ultrasound Hemiablation to Robotic Radical Prostatectomy in the Management of Unilateral Prostate Cancer: A Matched-Pair Analysis. Albisinni S; Aoun F; Bellucci S; Biaou I; Limani K; Hawaux E; Peltier A; van Velthoven R J Endourol; 2017 Jan; 31(1):14-19. PubMed ID: 27799004 [TBL] [Abstract][Full Text] [Related]
18. Salvage high-intensity focused ultrasound (HIFU) for locally recurrent prostate cancer after failed radiation therapy: Multi-institutional analysis of 418 patients. Crouzet S; Blana A; Murat FJ; Pasticier G; Brown SCW; Conti GN; Ganzer R; Chapet O; Gelet A; Chaussy CG; Robertson CN; Thuroff S; Ward JF BJU Int; 2017 Jun; 119(6):896-904. PubMed ID: 28063191 [TBL] [Abstract][Full Text] [Related]
19. High-intensity focused ultrasound therapy for clinically localized prostate cancer. Lee HM; Hong JH; Choi HY Prostate Cancer Prostatic Dis; 2006; 9(4):439-43. PubMed ID: 16847468 [TBL] [Abstract][Full Text] [Related]
20. Focal therapy for localised unifocal and multifocal prostate cancer: a prospective development study. Ahmed HU; Hindley RG; Dickinson L; Freeman A; Kirkham AP; Sahu M; Scott R; Allen C; Van der Meulen J; Emberton M Lancet Oncol; 2012 Jun; 13(6):622-32. PubMed ID: 22512844 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]